These authors found that OPLAH alone and/or a combination of a few methylated DNA markers (ARHGEF4, LRRC4, ANTXR1, PITX1) can discriminate adenomas and CRC in LS patients [39]. This evidence concerns the gene LRRC4 and colorectal carcinoma.